Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis

MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1

(2019) Ying Yang et al.   Nature Communications

miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-κB activation

(2019) Yongzheng Xie et al.   OncoTargets and Therapy

The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database

(2019) Wei Zhu et al.   PATHOLOGY & ONCOLOGY RESEARCH

miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway

(2019) Daqiong Jiang et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Prognostic Value of a Four-miRNA Signature in Patients with Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection

(2019) Jing Wen et al.   ANNALS OF SURGERY

Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis

(2019) Jun Zhou et al.   BIOSCIENCE REPORTS

Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma

(2019) Cheng-Yun Li et al.   CHINESE MEDICAL JOURNAL

MicroRNA-493 is a prognostic factor in triple-negative breast cancer

(2018) Ling Yao et al.   CANCER SCIENCE

Emerging roles of long non-coding RNA in cancer

(2018) Anna Sanchez Calle et al.   CANCER SCIENCE

The MiR-135b–BMAL1–YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance

(2018) Weiliang Jiang et al.   Cell Death & Disease

miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG

(2018) Yan Zhang et al.   Artificial Cells Nanomedicine and Biotechnology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis

(2018) Zeyu Wang et al.   OncoTargets and Therapy

Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis

(2018) Qingyu Zhang et al.   Biomed Research International

MicroRNA-135a is up-regulated and aggravates myocardial depression in sepsis via regulating p38 MAPK/NF-κB pathway

(2017) Ge Zheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

(2017) Rajesha Rupaimoole et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction

(2017) Farah J Nassar et al.   PHARMACOLOGY & THERAPEUTICS

Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma

(2017) Kuang-Tzu Huang et al.   Molecular Therapy-Nucleic Acids

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers

(2016) Tsutomu Kawaguchi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers

(2016) Chiranjib Chakraborty et al.   TUMOR BIOLOGY

Gastric cardia adenocarcinoma microRNA profiling in Chinese patients

(2016) Shegan Gao et al.   TUMOR BIOLOGY

miR-135a promotes gastric cancer progression and resistance to oxaliplatin

(2016) Lin-Hai Yan et al.   Oncotarget

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer

(2014) Nicola Valeri et al.   CANCER CELL

MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity

(2014) Orna Issler et al.   NEURON

The UCSC Cancer Genomics Browser: update 2015

(2014) Mary Goldman et al.   NUCLEIC ACIDS RESEARCH

Esophageal Cancer Management: Preoperative CA19.9 and CEA Serum Levels May Identify Occult Advanced Adenocarcinoma

(2014) Marco Scarpa et al.   WORLD JOURNAL OF SURGERY

MicroRNAs as novel biological targets for detection and regulation

(2013) Jinbo Li et al.   CHEMICAL SOCIETY REVIEWS

The Cancer Genome Atlas Pan-Cancer analysis project

(2013) John N Weinstein et al.   NATURE GENETICS

The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa

(2012) J. Gaedcke et al.   CLINICAL CANCER RESEARCH

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

(2011) C. C. Pritchard et al.   Cancer Prevention Research

MicroRNA 135 Regulates HOXA10 Expression in Endometriosis

(2011) Rafaella Petracco et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma

(2011) Shupeng Liu et al.   JOURNAL OF HEPATOLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Youden Index and Optimal Cut-Point Estimated from Observations Affected by a Lower Limit of Detection

(2008) Marcus D. Ruopp et al.   BIOMETRICAL JOURNAL

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

(2007) Jørn Wetterslev et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY